New York Partner Arthur Liederman participated in a settlement of approximately 4000 claims of various injuries and deaths involving the Boehringer Ingelheim anti-coagulant Pradaxa for $650 million. Acting on behalf of the company’s German insurers, our team worked with the insured and its outside defense counsel to negotiate a global settlement resolving both an Multi-District Litigation action pending in the USDC for the Southern District of Illinois and state court actions in California, Delaware and Connecticut.